Will residuals be paid? It’s complicated. By Jonathan Handel Ryan Kavanaugh - H 2015 Contrary to a published report, there is no “promise” that $8 million of Relativity funds will go to pay residuals.
At 36 months, the disease-free survival and molecular residual disease event-free rate was 86 vs 36% for patients in the osimertinib and placebo groups. HealthDay News — For patients with resected ...
Autofrettage is an established process in which controlled plastic deformation is induced in the inner layers of thick-walled cylinders to create beneficial compressive residual stresses. This ...
Phase I clinical trial using a unique immunotherapeutic combination of MUC1-targeted CAR-T cells with PD-1-knockout in the treatment of patients with advanced esophageal cancer. Fruquintinib plus ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results